guest ::
| Home > Publications database > Citrus intake and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC). > print |
| Home > Publications database > Citrus intake and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC). > print |
| 001 | 157248 | ||
| 005 | 20240229123133.0 | ||
| 024 | 7 | _ | |a 10.1007/s10654-020-00666-9 |2 doi |
| 024 | 7 | _ | |a pmid:32710289 |2 pmid |
| 024 | 7 | _ | |a 0393-2990 |2 ISSN |
| 024 | 7 | _ | |a 1573-7284 |2 ISSN |
| 024 | 7 | _ | |a altmetric:86674376 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-01505 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Mahamat-Saleh, Yahya |b 0 |
| 245 | _ | _ | |a Citrus intake and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC). |
| 260 | _ | _ | |a Dordrecht [u.a.] |c 2020 |b Springer Science + Business Media B.V. |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1609159098_26352 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2020 Nov;35(11):1057-1067 |
| 520 | _ | _ | |a Citrus intake has been suggested to increase the risk of skin cancer. Although this relation is highly plausible biologically, epidemiologic evidence is lacking. We aimed to examine the potential association between citrus intake and skin cancer risk. EPIC is an ongoing multi-center prospective cohort initiated in 1992 and involving ~ 520,000 participants who have been followed-up in 23 centers from 10 European countries. Dietary data were collected at baseline using validated country-specific dietary questionnaires. We used Cox proportional hazards regression models to compute hazard ratios (HR) and 95% confidence intervals (CI). During a mean follow-up of 13.7 years, 8448 skin cancer cases were identified among 270,112 participants. We observed a positive linear dose-response relationship between total citrus intake and skin cancer risk (HR = 1.10, 95% CI 1.03-1.18 in the highest vs. lowest quartile; Ptrend = 0.001), particularly with basal cell carcinoma (BCC) (HR = 1.11, 95% CI 1.02-1.20, Ptrend = 0.007) and squamous cell carcinoma (SCC) (HR = 1.23, 95% CI 1.04-1.47, Ptrend = 0.01). Citrus fruit intake was positively associated with skin cancer risk (HR = 1.08, 95% CI 1.01-1.16, Ptrend = 0.01), particularly with melanoma (HR = 1.23, 95% CI 1.02-1.48; Ptrend = 0.01), although with no heterogeneity across skin cancer types (Phomogeneity = 0.21). Citrus juice was positively associated with skin cancer risk (Ptrend = 0.004), particularly with BCC (Ptrend = 0.008) and SCC (Ptrend = 0.004), but not with melanoma (Phomogeneity = 0.02). Our study suggests moderate positive linear dose-response relationships between citrus intake and skin cancer risk. Studies with available biomarker data and the ability to examine sun exposure behaviors are warranted to clarify these associations and examine the phototoxicity mechanisms of furocoumarin-rich foods. |
| 536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Cervenka, Iris |b 1 |
| 700 | 1 | _ | |a Al-Rahmoun, Marie |b 2 |
| 700 | 1 | _ | |a Mancini, Francesca R |b 3 |
| 700 | 1 | _ | |a Severi, Gianluca |b 4 |
| 700 | 1 | _ | |a Ghiasvand, Reza |b 5 |
| 700 | 1 | _ | |a Veierod, Marit B |b 6 |
| 700 | 1 | _ | |a Caini, Saverio |b 7 |
| 700 | 1 | _ | |a Palli, Domenico |b 8 |
| 700 | 1 | _ | |a Botteri, Edoardo |b 9 |
| 700 | 1 | _ | |a Sacerdote, Carlotta |b 10 |
| 700 | 1 | _ | |a Ricceri, Fulvio |b 11 |
| 700 | 1 | _ | |a Trichopoulou, Antonia |b 12 |
| 700 | 1 | _ | |a Peppa, Eleni |b 13 |
| 700 | 1 | _ | |a La Vecchia, Carlo |b 14 |
| 700 | 1 | _ | |a Overvad, Kim |b 15 |
| 700 | 1 | _ | |a Dahm, Christina C |b 16 |
| 700 | 1 | _ | |a Olsen, Anja |b 17 |
| 700 | 1 | _ | |a Tjønneland, Anne |b 18 |
| 700 | 1 | _ | |a Perez-Cornago, Aurora |b 19 |
| 700 | 1 | _ | |a Jakszyn, Paula |b 20 |
| 700 | 1 | _ | |a Grioni, Sara |b 21 |
| 700 | 1 | _ | |a Schulze, Matthias B |b 22 |
| 700 | 1 | _ | |a Skeie, Guri |b 23 |
| 700 | 1 | _ | |a Lasheras, Cristina |b 24 |
| 700 | 1 | _ | |a Colorado-Yohar, Sandra |b 25 |
| 700 | 1 | _ | |a Rodríguez-Barranco, Miguel |b 26 |
| 700 | 1 | _ | |a Kühn, Tilman |0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe |b 27 |u dkfz |
| 700 | 1 | _ | |a Katzke, Verena A |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 28 |u dkfz |
| 700 | 1 | _ | |a Amiano, Pilar |b 29 |
| 700 | 1 | _ | |a Tumino, Rosario |b 30 |
| 700 | 1 | _ | |a Panico, Salvatore |b 31 |
| 700 | 1 | _ | |a Ezponda, Ana |b 32 |
| 700 | 1 | _ | |a Sonestedt, Emily |b 33 |
| 700 | 1 | _ | |a Scalbert, Augustin |b 34 |
| 700 | 1 | _ | |a Weiderpass, Elisabete |b 35 |
| 700 | 1 | _ | |a Boutron-Ruault, Marie-Christine |b 36 |
| 700 | 1 | _ | |a Kvaskoff, Marina |b 37 |
| 773 | _ | _ | |a 10.1007/s10654-020-00666-9 |0 PERI:(DE-600)2004992-4 |n 11 |p 1057-1067 |t European journal of epidemiology |v 35 |y 2020 |x 1573-7284 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:157248 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 27 |6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 28 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Cancer risk factors and prevention |x 0 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2020-01-23 |w ger |
| 915 | _ | _ | |a National-Konsortium |0 StatID:(DE-HGF)0430 |2 StatID |d 2020-01-23 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2020-01-23 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J EPIDEMIOL : 2018 |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2020-01-23 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-01-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2020-01-23 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR J EPIDEMIOL : 2018 |d 2020-01-23 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|